Horizant (REMEDYREPACK INC.)


Welcome to the PulseAid listing for the Horizant drug offered from REMEDYREPACK INC.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: REMEDYREPACK INC.
NON-PROPRIETARY NAME: gabapentin enacarbil
SUBSTANCE NAME: GABAPENTIN ENACARBIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-09-02
END MARKETING DATE: 0000-00-00


Horizant HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHorizant from REMEDYREPACK INC.
LABELER NAME: REMEDYREPACK INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/1)
START MARKETING DATE: 2016-09-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61786-858_5a46c12c-a8a5-2d43-e053-2991aa0abae3
PRODUCT NDC: 61786-858
APPLICATION NUMBER: NDA022399

Other GABAPENTIN ENACARBIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Arbor PharmaceuticalsHorizant
REMEDYREPACK INC.Horizant